{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T12:29:13Z","timestamp":1783254553671,"version":"3.54.6"},"update-to":[{"DOI":"10.1002\/14651858.cd000346","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[1999,4,26]],"date-time":"1999-04-26T00:00:00Z","timestamp":925084800000}}],"reference-count":77,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000346.pub2","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T07:08:53Z","timestamp":1090393733000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Gonadotrophin-releasing hormone analogues for pain associated with endometriosis"],"prefix":"10.1002","volume":"2010","author":[{"given":"Andrew","family":"Prentice","sequence":"first","affiliation":[{"name":"Rosie Maternity Hospital; Department of Obstetrics and Gynaecology; Robinson Way Cambridge UK CB2 2SW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Deary","sequence":"additional","affiliation":[{"name":"Addenbrooke's Hospital; Clinical Pharmacology; Hills Road Cambridge UK CB2 2QQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Goldbeck-Wood","sequence":"additional","affiliation":[{"name":"Ipswich Hospital; Obstetrics and Gynaecology\/Psychosexual Medicine; 92 Gilbert Rd Cambridge UK CB4 3PD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[{"name":"University of Auckland; Obstetrics and Gynaecology; FMHS Park Road Grafton Auckland New Zealand 1003"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Smith","sequence":"additional","affiliation":[{"name":"Imperial College; Faculty of Medicine; Exhibition Road London UK SW7-2BT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1999,4,26]]},"reference":[{"key":"10.1002\/14651858.CD000346.pub2-BIB1|cit1","first-page":"55","article-title":"Goserelin Depot versus danazol in the treatment of endometriosis. The Australian\/New Zealand experience","volume":"31","author":"Anonymous","year":"1996","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB2|cit2","first-page":"431","article-title":"A randomised comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis","volume":"57","author":"Chang","year":"1996","journal-title":"Chinese Medical Journal (Taipei)"},{"key":"10.1002\/14651858.CD000346.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0028-2243(94)02016-8","article-title":"A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis","volume":"59","author":"Cirkel","year":"1995","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"issue":"Suppl A","key":"10.1002\/14651858.CD000346.pub2-BIB4|cit4","first-page":"29","article-title":"Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial.","volume":"14","author":"Crosignani","year":"1992","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD000346.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0015-0282(16)53755-8","article-title":"Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group","volume":"54","author":"Dlugi","year":"1990","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0015-0282(16)60543-5","article-title":"Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study","volume":"51","author":"Dmowski","year":"1989","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0002-9378(89)90739-4","article-title":"Buserelin versus danazol in the treatment of endometriosis-associated infertility","volume":"161","author":"Fedele","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB8|cit8","first-page":"79","article-title":"Endometrial patterns during danazol and buserelin therapy for endometrosis: comparative structural and ultrastructural study","volume":"76","author":"Fedele","year":"1990","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0015-0282(16)55975-5","article-title":"Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1479-828X.1991.tb01807.x","article-title":"A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol","volume":"31","author":"Fraser","year":"1991","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0015-0282(16)58682-8","article-title":"Gestrinone versus a gonadotrophin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study","volume":"66","year":"1996","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB12|cit12","first-page":"215","article-title":"Pain of endometriosis: effects of nafarelin and danazol therapy","volume":"39","author":"Adamson","year":"1994","journal-title":"International Journal of Fertility and Menopausal Studies"},{"key":"10.1002\/14651858.CD000346.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/0002-9378(89)90870-3","article-title":"Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol [published erratum appears in Am J Obstet Gynecol 1989;161(6 Pt 1):1755]","volume":"160","author":"Burry","year":"1989","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD000346.pub2-BIB16|cit14","first-page":"1021","article-title":"Role of nafarelin in the management of endometriosis","volume":"34","author":"Henzl","year":"1989","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD000346.pub2-BIB14|cit15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial","volume":"318","author":"Henzl","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000346.pub2-BIB15|cit16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(90)90432-7","article-title":"Efficacy and safety of nafarelin in the tretment of endometriosis","volume":"162","author":"Henzl","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0015-0282(16)57530-X","article-title":"Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain","volume":"63","author":"Hornstein","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1995.tb02926.x","article-title":"Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis","volume":"43","author":"Howell","year":"1995","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0015-0282(16)57779-6","article-title":"Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial","volume":"64","author":"Howell","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0015-0282(16)57900-X","article-title":"Comparison of the gonadotrophin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometrioisis","volume":"64","author":"Kiilholma","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9378(88)90128-7","article-title":"Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis","volume":"158","author":"Lemay","year":"1988","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000414894","article-title":"LH-RH agonist treatment of endometriosis","volume":"16","author":"Lemay","year":"1987","journal-title":"Contributions to Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD000346.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0015-0282(16)57593-1","article-title":"Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin","volume":"63","author":"Dawood","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0002-9378(11)91718-9","article-title":"Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results","volume":"167","author":"Wheeler","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0002-9378(93)90126-4","article-title":"Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomised clinical trial. 2 Assessment of safety. Lupron Endometriosis Study Group","volume":"169","author":"Wheeler","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0015-0282(16)58096-0","article-title":"The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl)","volume":"65","author":"Lindsay","year":"1996","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0015-0282(16)58023-6","article-title":"Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis","volume":"65","author":"Makarainen","year":"1996","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9378(90)90438-D","article-title":"Effects of nafarelin versus danazol on lipids and calcium metabolism","volume":"162","author":"Bergquist","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD000346.pub2-BIB29|cit29","first-page":"1025","article-title":"Clinical experience treating endometriosis with nafarelin","volume":"34","author":"Claesson","year":"1989","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD000346.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0015-0282(16)54590-7","article-title":"Medical treatment of endometriosis: a comparison of the suppressive effects of danazol and nafarelin on reproductive hormones","volume":"56","author":"Hickok","year":"1991","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0015-0282(16)53574-2","article-title":"A comparison of nafarelin acetate and danazol in the treatment of endometriosis","volume":"53","author":"Kennedy","year":"1990","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)54893-6","article-title":"Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up","volume":"57","year":"1992","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0002-9378(90)90437-C","article-title":"Nafarelin versus danazol in the treatment of endometriosis","volume":"162","author":"Rolland","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(90)90433-8","article-title":"Nafarelin in the treatment of pelvic pain caused by endometriosis","volume":"162","author":"Shaw","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/jcem-69-6-1097","article-title":"Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis","volume":"69","author":"Valimaki","year":"1989","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD000346.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599009024979","article-title":"Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis","volume":"4","author":"Ylikorkala","year":"1990","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB37|cit37","first-page":"173","article-title":"Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol","volume":"46","author":"Palagiano","year":"1994","journal-title":"Minerva Ginecologica"},{"key":"10.1002\/14651858.CD000346.pub2-BIB38|cit38","first-page":"S49","article-title":"A multicenter comparison of GnRH agonist (Zoladex) and danazol in the treatment of endometriosis","volume":"56","author":"Rock","year":"1991","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB39|cit39","first-page":"329","article-title":"Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens","volume":"4","author":"Shaw","year":"1986","journal-title":"Clinical Reproduction and Fertility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB40|cit40","first-page":"558","article-title":"Reduction of vasomotor symptoms and bone mineral desity loss with combined norethindrone and long acting GnRH agonist therapy of symptomatic endometriosis: a prospective randomised trial","volume":"75","author":"Surrey","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD000346.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0015-0282(16)60542-3","article-title":"A randomised, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis","volume":"51","author":"Tummon","year":"1989","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB42|cit42","first-page":"S76","article-title":"A gonadotrophin releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"58","author":"Vercellini","year":"1992","journal-title":"Fertility & Sterility"},{"issue":"1","key":"10.1002\/14651858.CD000346.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0015-0282(16)56039-7","article-title":"A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis","volume":"60","author":"Vercellini","year":"1993","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0015-0282(16)55205-4","article-title":"An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team","volume":"58","author":"Shaw","year":"1992","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(16)60782-3","article-title":"Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol","volume":"52","author":"Dawood","year":"1989","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB46|cit46","first-page":"410","article-title":"Bone mass in endometriosis patients treated with GnRH agonist implant or danazol","volume":"77","author":"Dodin","year":"1991","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0015-0282(16)60783-5","article-title":"Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis","volume":"52","author":"Donnez","year":"1989","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.1992.tb02338.x","article-title":"A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone","volume":"37","author":"Eldred","year":"1992","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199412153312404","article-title":"Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency","volume":"331","author":"Finkelstein","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000346.pub2-BIB51|cit50","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/0020-7292(95)02510-J","article-title":"Changes in bone mineral content following hormone treatment for endometriosis","volume":"50","author":"Fukushima","year":"1995","journal-title":"International Journal of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD000346.pub2-BIB50|cit51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1447-0756.1993.tb00389.x","article-title":"Hormone treatment related bone mineral content changes in Japanese women with endometriosis","volume":"19","author":"Fukushima","year":"1993","journal-title":"Asia-Oceania Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/acta.0.1230405","article-title":"Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis","volume":"123","author":"Golland","year":"1990","journal-title":"Acta Endocrinologica"},{"key":"10.1002\/14651858.CD000346.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2265.1991.tb03541.x","article-title":"Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotriphin-releasing hormone (GnRH) agonist implant or by danazol","volume":"35","author":"Lemay","year":"1991","journal-title":"Clinics in Endocrinology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB56|cit54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/01443619109013535","article-title":"Pseudomenopause Treatment for Endometriosis: The Endocrine Effects of Danazol Compared with the use of the LH-RH Agonist Goserelin","volume":"11","author":"Maouris","year":"1991","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB54|cit55","series-title":"Silver Jubilee British Congress of Obstetrics and Gynaecology","first-page":"61","article-title":"Comparison of the endocrine effects of danazol and the LHRH agonist goserelin (Zoladex) in the treament of endometriosis","author":"Maouris","year":"1989"},{"key":"10.1002\/14651858.CD000346.pub2-BIB55|cit56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2265.1990.tb03891.x","article-title":"The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis","volume":"33","author":"Maouris","year":"1990","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB57|cit57","first-page":"211","article-title":"Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis- mulicenter trial in Japan","volume":"225","author":"Minanguchi","year":"1986","journal-title":"Progress in Clinical Biological Research"},{"key":"10.1002\/14651858.CD000346.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0015-0282(16)58351-4","article-title":"Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study","volume":"65","author":"Newton","year":"1996","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB59|cit59","first-page":"198","article-title":"Long term follow-up of endometriosis after two different therapies (Gestrinone and Buserelin)","volume":"23","author":"Nieto","year":"1996","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0002-9378(94)90136-8","article-title":"Nafarelin therapy in endometriosis: long-term effects on bone mineral density","volume":"171","author":"Orwoll","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0002-9378(94)90133-3","article-title":"Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial","volume":"171","author":"Parazzini","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD000346.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02106098","article-title":"Bone loss during gonadotrophin releasing hormone agonist treatment and use of nasal calcitonin","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis International"},{"key":"10.1002\/14651858.CD000346.pub2-BIB63|cit63","first-page":"581","article-title":"Effects of Sodium Etidronate in combination with low-dose Noretindrone in patients administered a long acting GnRH agonist: a preliminary report","volume":"81","author":"Surrey","year":"1993","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0015-0282(16)57476-7","article-title":"Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone \"add-back\" therapy","volume":"63","author":"Surrey","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2265.1990.tb00501.x","article-title":"The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis","volume":"33","author":"Whitehouse","year":"1990","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0015-0282(16)57417-2","article-title":"Short-term Lupron or danazol therapy for pelvic endometriosis","volume":"63","author":"Wright","year":"1995","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB67|cit67","first-page":"253","article-title":"A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis","volume-title":"Current Concepts in Endometriosis","author":"Dawood","year":"1990"},{"key":"10.1002\/14651858.CD000346.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)55792-6","article-title":"Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study","volume":"59","author":"Fedele","year":"1993","journal-title":"Fertility & Sterility"},{"key":"10.1002\/14651858.CD000346.pub2-BIB69|cit69","first-page":"227","article-title":"The effect of LHRH agonist therapy in the treatment of endometriosis (English experience)","volume":"225","author":"Jelley","year":"1986","journal-title":"Progress in Clinical & Biological Research"},{"issue":"Suppl","key":"10.1002\/14651858.CD000346.pub2-BIB70|cit70","first-page":"14","article-title":"Add-back therapy in the treatment of endometriosis: The North American experience.","volume":"103","author":"Moghissi","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology,"},{"key":"10.1002\/14651858.CD000346.pub2-BIB71|cit71","first-page":"175","article-title":"A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience","volume":"225","author":"Yee","year":"1986","journal-title":"Progress in Clinical Biological Research"},{"key":"10.1002\/14651858.CD000346.pub2-BIB72|cit72","first-page":"775","article-title":"Endometriosis and pelvic pain","volume":"7","author":"Barlow","year":"1993","journal-title":"Clinical Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-94-011-3864-2_7","article-title":"Endometriosis and Infertility","volume-title":"Modern Approaches to Endometriosis","author":"Thomas","year":"1991"},{"key":"10.1002\/14651858.CD000346.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0029-7844(95)00458-0","article-title":"Chronic pelvic pain: prevalence, health related quality of life, and economic correlates","volume":"87","author":"Mathias","year":"1996","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0957-5847(96)80021-7","article-title":"New Aspects of Pathogenesis of Endometriosis","volume":"6","author":"McLaren","year":"1996","journal-title":"Current Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD000346.pub2-BIB76|cit76","first-page":"51","article-title":"Endometriosis and Infertility","volume":"1","author":"Prentice","year":"1996","journal-title":"Journal of the British Fertility Society"},{"key":"10.1002\/14651858.CD000346.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-94-011-3864-2_14","article-title":"GnRH analogues in the treatment of endometriosis -rationale and efficacy","volume-title":"Modern Approaches to Endometriosis.","author":"Shaw","year":"1991"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD000346.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T18:01:10Z","timestamp":1705687270000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000346.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[1999,4,26]]},"references-count":77,"aliases":["10.1002\/14651858.cd000346","10.1002\/14651858.cd000346"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000346.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4,26]]}}}